Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, May 10 '25)

Image
By G.M.

 


    Ann Intern Med

  1. CLEMENTS CM, Carpenter CR
    In nonsevere influenza, antiviral drugs do not reduce mortality or hospital admissions; some shorten symptom duration.
    Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01324.
    PubMed         Abstract available


    Antiviral Res

  2. FAGE C, Loison S, Zwygart AC, Poli R, et al
    Influenza A(H1N1)pdm09 Virus Resistance to Baloxavir, Oseltamivir and Sialic Acid Mimetics in Single and Dual therapies: Insights from Human Airway Epithelia and Murine Models.
    Antiviral Res. 2025 May 3:106174. doi: 10.1016/j.antiviral.2025.106174.
    PubMed         Abstract available

  3. TAKASHITA E, Yasui Y, Ikegaya A, Saka K, et al
    Impact of the Polymerase Acidic Protein E199K Substitution in Influenza A Viruses on Baloxavir Susceptibility.
    Antiviral Res. 2025 May 3:106173. doi: 10.1016/j.antiviral.2025.106173.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  4. KOU L, Wan Y, Nemoto YL, Tsujita K, et al
    Role of membrane proximal actin regulators in SARS-CoV-2 spike-induced cell-cell fusion.
    Biochem Biophys Res Commun. 2025;766:151846.
    PubMed         Abstract available


    BMC Pediatr

  5. IMTIAZ A, Akkam AY, AlThumali LH, AlHarthi AM, et al
    Diagnostic accuracy of visual triage checklist in early recognition of COVID-19 cases in the pediatric population: A retrospective cohort study.
    BMC Pediatr. 2025;25:352.
    PubMed         Abstract available


    J Virol

  6. XIE Z, Yang J, Jiao W, Li X, et al
    Clade 2.3.4.4b highly pathogenic avian influenza H5N1 viruses: knowns, unknowns, and challenges.
    J Virol. 2025 May 9:e0042425. doi: 10.1128/jvi.00424.
    PubMed         Abstract available

  7. LI Y, Quan X, Chen R, Wang X, et al
    Adaptive selection of quasispecies during in vivo passaging in chickens, mice, and ferrets results in host-specific strains for the H9N2 avian influenza virus.
    J Virol. 2025 May 8:e0015125. doi: 10.1128/jvi.00151.
    PubMed         Abstract available


    JAMA

  8. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
    Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
    JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  9. PATTON ME, Moline HL, Whitaker M, Tannis A, et al
    Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:273-281.
    PubMed         Abstract available


    PLoS Comput Biol

  10. GROTBERG JB, Romano F, Grotberg JC
    Flow mechanisms of the air-blood barrier.
    PLoS Comput Biol. 2025;21:e1012917.
    PubMed         Abstract available

  11. POLCZ P, Reguly IZ, Tornai K, Juhasz J, et al
    Smart epidemic control: A hybrid model blending ODEs and agent-based simulations for optimal, real-world intervention planning.
    PLoS Comput Biol. 2025;21:e1013028.
    PubMed         Abstract available


    PLoS One

  12. LOOMANS-KROPP HA, Elsaid MI, Yi J, Kweon Y, et al
    Perceptions of COVID-19 risk among individuals with preexisting health conditions.
    PLoS One. 2025;20:e0320792.
    PubMed         Abstract available

  13. SIM J, Smith LE, Amlot R, Rubin GJ, et al
    Discrimination of a single-item scale to measure intention to have a COVID-19 vaccine.
    PLoS One. 2025;20:e0322503.
    PubMed         Abstract available

  14. PEER N, Mashiane T, Oris M, Mwangi K, et al
    Non-communicable disease and mental health care during the COVID-19 pandemic in South Africa: Perspectives from selected healthcare professionals and patients.
    PLoS One. 2025;20:e0318156.
    PubMed         Abstract available

  15. KALAIVANI M, Hemraj C, Varhlunchhungi V, Ramakrishnan L, et al
    Cardio-metabolic traits and its socioeconomic differentials among school children including metabolically obese normal weight phenotypes in India: A post-COVID baseline characteristics of LEAP-C cohort.
    PLoS One. 2025;20:e0321898.
    PubMed         Abstract available

  16. SHUVO SD, Aktar T, Khatun A, Hasan MM, et al
    Determinants of household's dietary diversity during the COVID-19 pandemic: A community-based study in rural Southwestern Bangladesh.
    PLoS One. 2025;20:e0322894.
    PubMed         Abstract available

  17. LAYTON JB, Lloyd PC, Peetluk LS, Jiao Y, et al
    Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States.
    PLoS One. 2025;20:e0320434.
    PubMed         Abstract available

  18. TASEW G, Abdella S, Bejiga B, Ayalew J, et al
    Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021.
    PLoS One. 2025;20:e0313791.
    PubMed         Abstract available

  19. RONCA DB, Mesquita LO, Oliveira D, Figueiredo ACMG, et al
    Excess weight is associated with neurological and neuropsychiatric symptoms in post-COVID-19 condition: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314892.
    PubMed         Abstract available

  20. AYADI W, Smaoui F, Gargouri S, Ferjani S, et al
    Use of allele-specific qPCR and PCR-RFLP analysis for rapid detection of the SARS-CoV-2 variants in Tunisia: A cheap flexible approach adapted for developing countries.
    PLoS One. 2025;20:e0321581.
    PubMed         Abstract available

  21. THEW HZ, Cheong AT, Ghazali SS, Lim PY, et al
    To develop online platform and determine its effectiveness in ENHANCING DIABetes knowledge among diabetes patients in primary CARE clinic (Enhancing-Diab-Care Study): Study protocol.
    PLoS One. 2025;20:e0323102.
    PubMed         Abstract available

  22. HEJAZIAN SS, Vemuri A, Vafaei Sadr A, Shahjouei S, et al
    The health-related quality of life among survivors with post-COVID conditions in the United States.
    PLoS One. 2025;20:e0320721.
    PubMed         Abstract available

  23. RAJLIC G, Sorensen JM, Shams B, Mardani A, et al
    Post-acute sequelae of COVID-19 in residents in long-term care homes: Examining symptoms and recovery over time.
    PLoS One. 2025;20:e0321295.
    PubMed         Abstract available

  24. BAGRIACIK U, Karakus R, Yaman M, Oruklu N, et al
    Increased serum levels of IL-40 are associated with IgA and NETosis biomarkers in Covid-19 patients: IL-40 and infectious diseases.
    PLoS One. 2025;20:e0321578.
    PubMed         Abstract available

  25. BREHON K, Hung P, Miciak M, Leung WM, et al
    Living with cystic fibrosis during the COVID-19 pandemic: An interpretive description of healthcare access from patients with cystic fibrosis and their providers in Alberta, Canada.
    PLoS One. 2025;20:e0322911.
    PubMed         Abstract available

  26. LI Y, Zhao IY, Lu W, Leung SF, et al
    Are people willing to take regular vaccinations? A qualitative study among diverse ethnic groups in Hong Kong.
    PLoS One. 2025;20:e0318631.
    PubMed         Abstract available

  27. HEJAZI S, Gholampour Kargar A, Ravanshad S, Ziaee A, et al
    Impact of COVID-19 on mucormycosis presentation and laboratory values: A comparative analysis.
    PLoS One. 2025;20:e0321897.
    PubMed         Abstract available

  28. MATHKOUR A, Alzahrani AH, Narapureddy BR, Alqahtani FM, et al
    Prevalence and risk factors of burnout among employees at COVID-19 vaccination centers: A cross-sectional study.
    PLoS One. 2025;20:e0322803.
    PubMed         Abstract available

  29. LAGARE A, Perthame E, Lazoumar RH, Aboutalib FA, et al
    Climatic factors driving influenza transmission in Sahelian area: A twelve-year retrospective study in Niger (2010-2021).
    PLoS One. 2025;20:e0322288.
    PubMed         Abstract available

  30. WANG M, Kong R, Wang Y
    Probing the intrinsic mechanism and evolution characteristics of online shopping customer satisfaction via text mining of online reviews.
    PLoS One. 2025;20:e0321202.
    PubMed         Abstract available

  31. RAMALATA A, Adekpedjou A, Lesaoana M
    Variable selection in mixture cure models using elastic net penalty: application to COVID-19 data.
    PLoS One. 2025;20:e0320521.
    PubMed         Abstract available

  32. ORTIZ GARCIA P, Manzanera-Roman S
    Importance of occupation in the increase of gender differences in the advance of telework in Spain.
    PLoS One. 2025;20:e0322847.
    PubMed         Abstract available

  33. DELGADO I, Dahal S, Matute MI, Rubilar Ramirez PA, et al
    Socioeconomic inequalities in Chile during the COVID-19 pandemic: A regional analysis of income poverty.
    PLoS One. 2025;20:e0323409.
    PubMed         Abstract available

  34. ABBAS U, Hussain N, Tanveer M, Laghari RN, et al
    Frequency and predictors of depression and anxiety in chronic illnesses: A multi disease study across non-communicable and communicable diseases.
    PLoS One. 2025;20:e0323126.
    PubMed         Abstract available

  35. RIJAL A, Murhandarwati EEH, Banjara MR, Kc D, et al
    Exploring barriers and facilitators in implementation fidelity of malaria screening intervention at Nepal-India border point-of-entry health desks-A mixed method study.
    PLoS One. 2025;20:e0323116.
    PubMed         Abstract available

  36. WACHIRA N, Juttla PK, Kimani B, Kamita M, et al
    Community health volunteers' experiences during the COVID-19 pandemic in Kiambu county, Kenya: A qualitative study.
    PLoS One. 2025;20:e0322642.
    PubMed         Abstract available

  37. CHEN MY, Du J, Do BK, Ali MH, et al
    Comparing visual outcomes of nAMD treatment during and after the COVID-19 restrictions period.
    PLoS One. 2025;20:e0323253.
    PubMed         Abstract available


    Vaccine

  38. AKMATOVA R, Otorbaeva D, Ebama MS
    Impact of the COVID-19 pandemic on influenza knowledge, attitudes, and vaccination practices in at-risk groups in the Kyrgyz Republic: A comparative study.
    Vaccine. 2025;56:127159.
    PubMed         Abstract available

  39. OTORBAEVA D, Akmatova R, Cooley KM, Iwamoto C, et al
    Corrigendum to "Post-introduction evaluation (PIE) of the seasonal influenza vaccination program in Kyrgyzstan in 2023" Vaccine 55 (2025) 127052.
    Vaccine. 2025;56:127123.
    PubMed        

  40. PITTER JG, Mihajlovic J, Nagy D, van der Schans J, et al
    Underreported influenza mortality in Central and Eastern Europe hinders the extension of seasonal influenza vaccination programs in older adults.
    Vaccine. 2025;56:127184.
    PubMed         Abstract available

  41. ASHRAF U, Lee A, Gao Q, Gonzalez JC, et al
    Impact of age and prior COVID-19 on the response to influenza a components in the 2020-2021 Fluzone vaccine.
    Vaccine. 2025;56:127171.
    PubMed         Abstract available

  42. RAHA JR, Kim KH, Le CTT, Bhatnagar N, et al
    Intranasal vaccination with multi-neuraminidase and M2e virus-like particle vaccine results in greater mucosal immunity and protection against influenza than intramuscular injection.
    Vaccine. 2025;57:127206.
    PubMed         Abstract available

  43. MASHAMBA M, Msibi T, Tshabalala G, Tsotetsi L, et al
    Factors influencing influenza vaccine uptake among adults in Johannesburg, South Africa: A qualitative study.
    Vaccine. 2025;57:127133.
    PubMed         Abstract available


    Virology

  44. REUSS D, Brown JC, Sukhova K, Furnon W, et al
    Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium.
    Virology. 2025;608:110556.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »